Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.44NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.350ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.350ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.350ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.350NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.304ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.304ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.304ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.304NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.315ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.315ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.315ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.315NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.516ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.516ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.516ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.516NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.354ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.354ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.354ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.354NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.162ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.162ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.162NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.426ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.426ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.426ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.426NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.402ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.402ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.402ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.402NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.424ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.424ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.424ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.424NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.61ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.61ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.61NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.264ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.264ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.264ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.264NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.581ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
B.1.581ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.581ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used